ArticleLipids in health and disease2025
Lipid infiltration promotes trans-differentiation of vascular smooth muscle cells into macrophage-like cells in early lesions of human coronary atherosclerosis.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Pharmacological targeting of the senescence-associated secretory phenotype in atherosclerosis: therapeutic potential of senolytics and senomorphics.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy.JACC. Asia · 2026Review
- VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.Frontiers in immunology · 2026Review
- Article
- Dysregulated cellular metabolism drives atherosclerotic plaque progression: a multi-cellular perspective.Frontiers in cardiovascular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe trans-differentiation of vascular smooth muscle cells (VSMCs) into macrophage-like phenotypes contributes substantially to the advancement of atherosclerotic lesions. However, it remains uncertain whether this trans-differentiation is involved in the early pathogenesis of human coronary atherosclerosis. Given that lipid deposition is a pathological hallmark of early-stage atheroma and that single-cell evidence implicates lipid-processing signatures in VSMC trans-differentiation, it was hypothesized that lipid infiltration critically triggers this process during the early stages of coronary atherosclerosis.
methodsClinical information and lipid profiles were collected from 38 heart transplant recipients. Coronary artery specimens were obtained from their explanted hearts and classified as initial lesions, fatty streaks, or advanced lesions. Immunohistochemical (IHC) staining and immunofluorescence (IF) analyses were performed on the tissue samples to assess lipid infiltration, VSMC phenotype, and trans-differentiation.
resultsLipid infiltration and VSMC phenotype switching were observed at the initial lesion stage. IHC and semi-quantitative analysis showed that with increasing lipid infiltration, the densities of foam cells, fatty acid binding protein 4 (FABP4)
conclusionsLipid infiltration begins in the early stages of human coronary artery atherosclerotic lesions and may promote trans-differentiation of intimal SMCs into macrophage-like cells, as indicated by expression of the macrophage-associated protein FABP4. These findings provide novel insight into early atherogenesis and may help identify potential targets for timely prevention and intervention in cardiovascular disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.